Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient.
暂无分享,去创建一个
D. Neau | J. Ragnaud | H. Fleury | H. Dutronc | E. Schvoerer | F. Dubois | D. Robert
[1] E. Schiff,et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.
[2] S. Lawrence,et al. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] S. Schalm,et al. Hepatitis B reactivation after lamivudine , 1995, The Lancet.
[4] P. Angus,et al. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation , 1995, Hepatology.
[5] J. Wands,et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.